NCT05526404已完成不适用
Mobile Application Based Lactulose Titration for Prevention of Hepatic Encephalopathy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Achievement of daily stool goal
研究概览
简要总结
This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ability to provide written, informed consent.
- •Currently taking lactulose daily for prevention of hepatic encephalopathy.
排除标准
- •Recent change in dosing of opioid medication.
- •Previous Colorectal Surgery.
- •Active diarrheal illness.
- •Lack of smartphone or other smart device at home.
结局指标
主要结局
Achievement of daily stool goal
时间窗: 4 weeks
Number of subject to achieve daily stool goal, determined if use of the mobile application leads to improved rates of meeting daily stool goal (3-4 stools per day of Bristol Stool Scale 3-4)
次要结局
未报告次要终点
研究者
Douglas (Doug) A. Simonetto
Principal Investigator
Mayo Clinic
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Mobile App Logging for Diabetes in PregnancyGestational Diabetes Mellitus in PregnancyType 2 DiabetesNCT06005987Carolyn Zahler-Miller40
已完成
不适用
Mobile Application Utilization for Measurement of Scapular PositionShoulder PainNCT02773654University of Minnesota50
尚未招募
不适用
The Use of Artificial Intelligence (AI) for Gait AnalysisGaitNCT06289231Gdansk University of Physical Education and Sport50
已完成
不适用
Smartphone Application Based Reminder Therapy in Orthodontic PatientsOrthodontic Appliance ComplicationNCT05001490Rehman Medical Institute - RMI60
已完成
不适用
Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in BotswanaJaundice, NeonatalNCT06372093Picterus AS172